The IL-1 TRAP brand, founded in 2009 (United States), from 16 sister brands and 2214 competing brands. IL-1 TRAP is owned by Regeneron Pharmaceuticals, listed on the stock exchange of New York IL-1 TRAP belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
Regeneron Pharmaceuticals
(IL-1 TRAP)
over 5 years*
USD 2,276.96